FDA Drug Application (205921) for NEVIRAPINE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number205921
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage400MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEVIRAPINE
Active IngredientNEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient NEVIRAPINE17


Back to FDA Applications sponsored by MYLAN LABS LTD